Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Cohance Lifesciences Q4 net profit tanks 84%; sees recovery from FY27 second half
EBITDA fell 60% year-on-year to ₹98.7 crore from ₹229.2 crore a year earlier. The EBITDA margin shrank to 15.9% from 27.3% YoY. Shares of Cohance Lifesciences Ltd ended at ₹485.75, up by ₹7.10, or 1.48%, on the BSE.
Q4 Results LIVE Updates: Dr. Reddy's, Dixon report results today; Indian Hotels, Anant Raj react
Q4 Results LIVE Updates: Its an earnings-heavy day on the Dalal Street today. Nifty 50 stock Dr Reddy's Laboratories is scheduled to report its numbers today. Dixon Tech, Berger Paints, Nazara Tech, INOX India, Cohance Lifesciences, Gopal Snacks, Kalpataru, KPR Mill, Max Financial Services, MobiKwik, MTAR Tech, Novartis, Pfizer, Religare, Keystone Developers, Sagility, Tata Power, Torrent Power, Texmaco Rail, V-Guard Industries, are among the other important results to track today. Watch this space for all the LIVE earnings updates.
Gainers & Losers: GRSE, Vedanta among 8 big movers on Wednesday
Indian markets closed higher led by auto, FMCG, and IT stocks. Strong Q4 earnings drove gains in GRSE, CEAT, and Vedanta, while REC, Cohance Lifesciences, and India Cements declined.
Cohance Lifesciences shares need to cross this level to recover all the losses for 2026
Cohance Lifesciences shares have advanced in four of the past seven sessions and is now attempting to recover its losses for 2026. The key level to watch is ₹528, which the stock had touched on December 31, 2025.
Third-worst performing smallcap stock of 2026 gets a big name as CEO; Shares jumps 20%
Cohance's current executive Chairman Vivek Sharma will be stepping down for personal reasons, but will continue to remain with the company for the next nine months as an advisor and help in a smooth transition.
Cohance Lifesciences Block Deal: Shares rally 10% after ₹216 crore worth equity changes hands
As many as 70 lakh shares, or 1.82% of Cohance Lifesciences' equity, worth ₹216.3 crore changed hands in a block deal window.
Cohance shares decline 2% as company CFO resigns
Agarwal was appointed Chief Financial Officer in January 2024. The company has not announced a successor.
Stocks to Watch Today: Texmaco Rail, RVNL, PNC Infratech, Dr Reddys Labs, MTAR Tech, Cohance Life, Gopal Snacks, Kalpataru Projects in focus on 13 May
Stocks to Watch, 13 May: Stocks like Dr Reddys Laboratories, Tata Power Company, Torrent Power, Nazara Technologies, Sagility, Kalpataru, Neuland Laboratories, Dixon Technologies, Gopal Snacks, Texmaco Rail and Engineering, Cohance Lifesciences, Rail Vikas Nigam, and PNC Infratech will be in focus on May 13.